ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: TH-PO1129

Diffusion MRI Detects an Increase in Interstitial Fibrosis Earlier Than the Decline of Renal Function

Session Information

Category: Transplantation

  • 1902 Transplantation: Clinical


  • Berchtold, Lena, Hôpitaux Universitaire de Genève, Geneva, Switzerland
  • Moll, Solange, University Hospital of Geneva, Geneva, Switzerland
  • Martin, Pierre-Yves F., Hospital Universitaire de Geneve, Geneva City, Switzerland
  • De Seigneux, Sophie M., Hôpitaux Universitaire de Genève, Geneva, Switzerland

Interstitial fibrosis(IF) is one of the major predicting factors in CKD. Diffusion Weighted Magnetic resonance imaging(DWI-MRI) is a new tool for non–invasive IF assessment, but its value for IF follow up is unknown. We recently adapted a DWI sequence, allowing for the discrimination between the kidney cortex and medulla. The cortico-medullary ADC difference(ΔADC) was better correlated to IF than absolute ADC. We aimed at analyzing the use of DWI-MRI for the follow up of IF in patients having undergone repeated biopsies in comparison to renal function evolution.


In this prospective study, we included patients having undergone repeated biopsies for clinical purpose and who agreed to undergo repeated DWI-MRI at the time of biopsy.


19 kidney allografts patients had repeated biopsies for clinical purposes and parallel MRI examinations. The average interval between the two biopsies was 1.7year. There was no significant correlation between eGFR and IF at baseline(r=-0.39,p=0.10), whereas baseline ΔADC correlated negatively with IF(r=-0.76,p<0.001). Between the two visits, IF as estimated from the biopsy, increased significantly from a fibrosis score of 20% to 32.5%(p=0.03) in individual patients, whereas estimated renal function remained stable(eGFR 54 to 52ml/min/1.73m2;p=0.19). ΔADC decreased significantly from 30 to -23 x10-6mm2/S(Figure A). Considering the difference between the basal and follow-up values, there was a good correlation between the evolution of IF and ΔADC(r=-0.51,p=0.03)(Figure B) but not between the evolution of IF and eGFR (r=0.24,p=0.34).


Thus modifications of ΔADC derived from DWI-MRI outperformed eGFR to follow IF evolution within a given patient. ΔADC may be more reliable than eGFR to allow earlier detection of an increase in IF.


  • Government Support - Non-U.S.